Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Fredrik EkChemical Biology & Therapeutics, Department of Experimental Medical Science, Lund University, Lund, SE-221 84, Sweden.ORCID 0000-0002-5651-8445
Tobias AbrahamssonLaboratory of Organic Electronics, Department of Science and Technology, Linköping University, Norrköping, 601 74, Sweden.ORCID 0000-0002-3615-1850
Marios SavvakisLaboratory of Organic Electronics, Department of Science and Technology, Linköping University, Norrköping, 601 74, Sweden.ORCID 0000-0002-0078-5149
Stefan BormannChemical Biology & Therapeutics, Department of Experimental Medical Science, Lund University, Lund, SE-221 84, Sweden.
Abdelrazek H MousaDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, SE-405 30, Sweden.ORCID 0000-0002-4050-9253
Muhammad Anwar ShameemDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, SE-405 30, Sweden.ORCID 0000-0001-6173-3417
Karin HellmanChemical Biology & Therapeutics, Department of Experimental Medical Science, Lund University, Lund, SE-221 84, Sweden.ORCID 0000-0001-5957-7160
Amit Singh YadavChemical Biology & Therapeutics, Department of Experimental Medical Science, Lund University, Lund, SE-221 84, Sweden.ORCID 0000-0002-5118-4538
Lazaro Hiram BetancourtDivision of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, SE-221 84, Sweden.ORCID 0000-0001-8207-7041
Peter EkströmChemical Biology & Therapeutics, Department of Experimental Medical Science, Lund University, Lund, SE-221 84, Sweden.ORCID 0000-0001-9010-4388
Jennifer Y GerasimovLaboratory of Organic Electronics, Department of Science and Technology, Linköping University, Norrköping, 601 74, Sweden.ORCID 0000-0003-2974-0881
Daniel T SimonLaboratory of Organic Electronics, Department of Science and Technology, Linköping University, Norrköping, 601 74, Sweden.ORCID 0000-0002-2799-3490
György Marko-VargaDivision of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, SE-221 84, Sweden.ORCID 0000-0001-7140-8925
Martin HjortChemical Biology & Therapeutics, Department of Experimental Medical Science, Lund University, Lund, SE-221 84, Sweden.
Magnus BerggrenLaboratory of Organic Electronics, Department of Science and Technology, Linköping University, Norrköping, 601 74, Sweden.ORCID 0000-0003-4791-4785
Xenofon StrakosasLaboratory of Organic Electronics, Department of Science and Technology, Linköping University, Norrköping, 601 74, Sweden.ORCID 0000-0001-5757-8565
Roger OlssonChemical Biology & Therapeutics, Department of Experimental Medical Science, Lund University, Lund, SE-221 84, Sweden.ORCID 0000-0002-7107-3472
Funding
European Research Council 834677European Research Council AdG 2018Stiftelsen för Strategisk Forskning RMX18-0083Swedish Research Council 2018-05258Swedish Research Council 2018-06197Swedish Research Council 2023-04965
6 · The paper itself
Abstract
Bioelectronics holds great potential as therapeutics, but introducing conductive structures within the body poses great challenges. While implanted rigid and substrate-bound electrodes often result in inflammation and scarring in vivo, they outperform the in situ-formed, more biocompatible electrodes by providing superior control over electrode geometry. For example, one of the most researched methodologies, the formation of conductive polymers through enzymatic catalysis in vivo, is governed by diffusion control due to the slow kinetics, with curing times that span several hours to days. Herein, the discovery of the formation of biocompatible conductive structures through photopolymerization in vivo, enabling spatial control of electrode patterns is reported. The process involves photopolymerizing novel photoactive monomers, 3Es (EDOT-trimers) alone and in a mixture to cure the poly(3, 4-ethylenedioxythiophene)butoxy-1-sulfonate (PEDOT-S) derivative A5, resulting in conductive structures defined by photolithography masks. These reactions are adapted to in vivo conditions using green and red lights, with short curing times of 5-30 min. In contrast to the basic electrode structures formed through other in situ methods, the formation of specific and layered patterns is shown. This opens up the creation of more complex 3D layers-on-layer circuits in vivo.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
In Vivo Photopolymerization: Achieving Detailed Conducting Patterns for Bioelectronics. · full record | OpenQuestion